A single-arm, open-label study to assess the overall safety of rovalpituzumab tesirine in participants with relapsed or refractory delta-like protein 3 (DLL3) expressing small cell lung cancer by evaluating the frequency of high grade (>= Grade 3) s
This study will evaluate the safety and preliminary efficacy of venetoclax when combined with lenalidomide and dexamethasone for participants with newly diagnosed, active t(11;14) positive multiple myeloma (MM).
This study will be conducted in two stages and will test the safety/tolerability, pharmacokinetics (how the body handles study drug) and pharmacodynamics (effects on the immune system and the virus) of the study drug ABBV-181 in Human immunodeficiency
Parkinson's disease (PD) is a neurological condition, which affects the brain. PD gets worse over time, but how quickly it progresses varies a lot from person to person. Some symptoms of PD are tremors, stiffness, and slowness of movement.
This is an efficacy and safety study evaluating a new treatment for subjects with mild to moderate Alzheimer's disease.
A study to evaluate the efficacy and tolerability of an active drug plus FOLFIRI compared to bevacizumab plus FOLFIRI in participants with previously treated metastatic adenocarcinoma of the colon or rectum.
Phase 2 Study of an active drug in Advanced Hepatocellular Carcinoma (HCC)
The objectives of this trial are primarily to evaluate the efficacy and safety of an active drug as compared to placebo over a 24-week treatment period in severe asthma patients.
Study M15-722 is a Phase 2a study to investigate the efficacy and safety of an active drug in participants with moderate to severe UC who failed prior therapy.
The Study Evaluating Efficacy And Tolerability of an active drug in Combination with Temozolomide or an active drug/Placebo in Combination with Carboplatin and Paclitaxel in Subjects with locally recurrent Breast Cancer not amenable to therapy with cur